| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▲ | 1.16▲ | 1.16▲ | 1.21▼ | 1.35▼ |
| MA10 | 1.16▲ | 1.15▲ | 1.16▲ | 1.26▼ | 1.53▼ |
| MA20 | 1.15▲ | 1.17▲ | 1.23▼ | 1.35▼ | 1.53▼ |
| MA50 | 1.19▼ | 1.26▼ | 1.28▼ | 1.53▼ | 2.82▼ |
| MA100 | 1.24▼ | 1.32▼ | 1.39▼ | 1.56▼ | N/A |
| MA200 | 1.35▼ | 1.48▼ | 1.54▼ | 1.70▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.006▲ | -0.002▼ | -0.015▼ | 0.089▲ |
| RSI | 54.431▲ | 46.088▼ | 42.389▼ | 34.397▼ | 37.380▼ |
| STOCH | 70.833 | 65.385 | 55.051 | 22.629 | 22.450 |
| WILL %R | 0.000▲ | 0.000▲ | -55.172 | -85.377▼ | -90.789▼ |
| CCI | 121.739▲ | 111.594▲ | 4.106 | -111.083▼ | -150.771▼ |
| ▲ GAP | $MTVA Open Gap Up %2 | Set Alert |
|
Thursday, September 10, 2026 05:24 AM
On September 9, 2026, MetaVia, Inc. (NASDAQ: MTVA) announced the results of a preclinical study utilizing radioactively labeled DA-1726 to evaluate its tissue distribution following subcutaneous ...
|
|
Wednesday, August 12, 2026 09:20 AM
Dose Titration Complete in Phase 1 Part 3 Study of DA-1726 MetaVia, Inc. (NASDAQ: MTVA) is currently conducting Part 3 of the Phase 1 study of DA-1726, the company’s oxyntomodulin analog agonist that ...
|
|
Wednesday, August 05, 2026 05:01 PM
MetaVia (MTVA) stock news, price prediction, earnings and analysis from 24/7 Wall St. MetaVia Inc. is a clinical-stage biotechnology company focused ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/10/26 | 1.165 | 1.18 | 1.165 | 1.18 | 18,437 |
| 28/10/26 | 1.17 | 1.1899 | 1.11 | 1.14 | 93,172 |
| 27/10/26 | 1.27 | 1.27 | 1.15 | 1.15 | 67,681 |
| 26/10/26 | 1.41 | 1.41 | 1.215 | 1.215 | 135,384 |
| 23/10/26 | 1.39 | 1.50 | 1.36 | 1.38 | 99,600 |
| 22/10/26 | 1.35 | 1.3948 | 1.35 | 1.39 | 32,973 |
| 21/10/26 | 1.29 | 1.37 | 1.29 | 1.34 | 42,149 |
| 20/10/26 | 1.26 | 1.305 | 1.20 | 1.29 | 21,017 |
| 19/10/26 | 1.29 | 1.30 | 1.225 | 1.23 | 54,238 |
| 16/10/26 | 1.38 | 1.43 | 1.26 | 1.26 | 75,725 |
|
|
||||
|
|
||||
|
|